#Editorial Mirvetuximab soravtansine: an oasis in the desert? 🏜️ Luisa Bonilla Lawrence Kasherman Ainhoa Madariaga 📌 bit.ly/3Tzg24A Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc

Early Career Clinicians Workshop “Research is not complete until it’s published and presented” Dr Yeh Chen Lee “The importance of a mentor “to guide and DRAG you through” Dr Silipa Naiquiso * Mentors - we all need them, and also need to become them A/Prof Emma Allanson

Multicenter cohort of patients with stage IA p53 abnormal #endometrialcancer without myometrial invasion had 16% risk for recurrent disease with most having distant pattern of recurrence. ijgc.bmj.com/content/34/4/5… IJGC Amy Jamieson #gyncsm #gynonc

🚨Survivorship Care for People affected by Advanced or Metastatic Cancer🚨 💥 MASCC-ASCO Standards / Practice Recommendations now published💥 ‼️ Clinical tools online ‼️ 14 languages (coming soon) Co-published open access: ascopubs.org/doi/full/10.12… and link.springer.com/article/10.100…

A joint MASCC-ASCO initiative ➡️ new global standards & practice recs for the consistent provision of high quality #survivorship care to people with advanced or metastatic #cancer & their caregivers 👏 JCO Oncology Practice Nicolas Hart Professor Ray Chan MASCC thelimbic.com/oncology/new-g…

BMI >40 is equivalent as a LIFETIME risk factor for Endometrial cancer to smoking 5 cigs/day as a risk factor for Lung cancer - Emma Crosbie's emphasis on the need for primary prevention in high-risk populations at #ASCO2024 This is a public health concern. ANZGOG

Uterine (endometrial) cancer is a global issue. Connecting with other world leaders in research is critical to improving treatments and outcomes for women with gynaecological cancer across the world.

Groundless complaints can drive doctors away. Here’s why patients need to be held accountable | Ranjana Srivastava theguardian.com/commentisfree/…

Congratulations Lawrence Kasherman winner of the young Onc oral prize! Fantastic research with @janette_vardy A/Prof Jo Shaw Ash Malalasekera Sim (Cindy) Tan So great to be flying the flag for qualitative research in survivorship and with CALD populations! #MOGA24 Medical Oncology Group of Australia (MOGA)

Join us this Friday, 🗓️30 August, 📷 ONLINE, 📷#CALD #chinese focused update on Intimacy Changes in Cancer Survivorship. Live translation in Mandarin too! Register using link: trybooking.com/events/landing…

👀Seeking GP expertise to inform policies and health systems on how to support provision of cancer survivorship in primary care Developed by GPs, for GPs! To take part in our national survey please go to qualtrics.flinders.edu.au/jfe/form/SV_3J… Thank you 🙏 Caring Futures Cancer Survivorship Program PC4 COSA Survivorship

Concerned about time toxicity affecting your patients? Contribute to research on this topic by responding to a questionnaire at redcap.slhd.nsw.gov.au/surveys/?s=EFD…

Now, lets consider Erman Akkus points Point #1. Patients on the control arm get Atezo-Bev or Sorafenib or Lenva-Pembro when they progress, so this will 'affect' OS He has to backwards! You WANT them to get the best care, and you have to PROVE treating earlier is better!

Does belonging to multiple disadvantaged groups = worse health? 🤔 My review shows that it does. This is why clinical trials must address intersectionality if we are to properly tackle health inequalities. #ICTMC2024 #PhD #ClinicalTrials #Intersectionality

After months of planning, we are finally kicking off the AC2 Leadership Forum today! AC2 is a project led by the Caring Futures Institute, Flinders University and our partners across Australia, and countries in the Asia-Pacific region. Gareth Williams

Great summary of survivorship in Australia - practice and research - by Janette Vardy including opportunities to progress #AC2Forum Caring Futures Cancer Survivorship Program

Great to be a part of the AC2 leaders forum in Hong Kong, working towards further collaborations in #CancerSurvivorship care for Chinese speaking populations #survonc @janette_vardy A/Prof Carolyn Ee MBBS Chad Han, AdvAPD, PhD Professor Ray Chan

#CancerSurvivorship We are looking forward to share our road map to ensure that AC2 is sustainable, with continued collaborations with our key stakeholders and to identify funding opportunities to continue advancing cancer survivorship care for people with Chinese backgrounds.

Come and join me as I share reflections on the role of art in the practice of oncology. Excellent panel. Lots of food for thought. Bonus: it will also be a visual feast. #cosa2024

🚨Our latest meta-analysis (1st of a 2-part series): - Pts in comprehensive #cancer centers (CCC) have 23% ↓ overall mortality risk compared to non-CCC - Mixed results re time to care/ #pallonc - Look out for our next article on CCCs worldwide Read here👉tinyurl.com/jhadn4ua